国药一致(000028) - 2018 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2018 was CNY 10,256,566,731.51, representing a 0.33% increase compared to CNY 10,222,459,812.55 in the same period last year[8]. - Net profit attributable to shareholders was CNY 292,731,685.33, reflecting a 7.40% increase from CNY 272,564,318.71 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was CNY 284,982,162.39, up by 5.06% from CNY 271,249,398.43 in the previous year[8]. - Basic and diluted earnings per share increased to CNY 0.68, up 6.25% from CNY 0.64 in the previous year[8]. - The company had a weighted average return on equity of 3.07%, slightly down from 3.17% in the previous year[8]. Cash Flow - The net cash flow from operating activities was negative at CNY -864,716,289.96, a decline of 72.16% compared to CNY -502,263,276.11 in the same period last year[8]. - Net cash flow from operating activities decreased by CNY 362 million, a decline of 72.16%, primarily due to a decrease in cash received from sales of goods and services[17]. - Investment activities generated a net cash flow increase of CNY 176 million, a growth of 79.86%, mainly due to the absence of last year's restructuring equity payments[17]. - Cash received from financing activities increased by CNY 111.25 million, a growth of 50.77%, primarily due to an increase in factoring financing[17]. - Cash flow from investment activities decreased by CNY 359.27 million, a decline of 41.60%, due to the absence of last year's restructuring project guarantee deposits[17]. - Cash paid for the purchase of fixed assets and intangible assets increased by CNY 132.19 million, a growth of 35.18%, due to increased expenditures for new retail store openings[17]. Assets and Shareholder Equity - Total assets at the end of the reporting period were CNY 23,760,905,981.51, a 6.34% increase from CNY 22,343,643,527.77 at the end of the previous year[8]. - Net assets attributable to shareholders reached CNY 9,689,304,031.21, marking a 3.12% increase from CNY 9,396,572,345.88 at the end of the previous year[8]. - The total number of ordinary shareholders at the end of the reporting period was 17,838[12]. Non-Recurring Items - Non-recurring gains and losses totaled CNY 7,749,522.94, primarily from the disposal of non-current assets and government subsidies[9]. - Other income increased by CNY 331,500, a growth of 30.46%, mainly due to an increase in government subsidies received[17]. - Asset disposal income increased by CNY 3.80 million, a growth of 11,709.29%, primarily due to government compensation for property acquisition[17]. Employee Compensation - Employee compensation payable decreased by CNY 70.95 million, a decline of 32.90%, mainly due to the payment of last year's accrued employee compensation[17]. Commitments - The company has not reported any overdue commitments from controlling shareholders or related parties during the reporting period[21].